The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.
Confirm
Session Chairs: Chris Chumsae, Bristol-Myers Squibb Company and Frances Namuswe, CDER, FDA
Session Speakers:
Glyco-Analysis of a Glycoengineered VHH-Radioligand Therapy Designed for Improved Biodistribution
David Bush, Novartis
Characterization of ADCs in Serum and Formulation Buffer
Tun Liu, Johnson & Johnson
Development of Novel Chromatographic and Mass Spectrometric Techniques for Characterizations of BsAbs and ADCs
Fengfei Ma, Merck & Co., Inc.